American Century Companies’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Buy
174,062
+115,320
+196% +$263K ﹤0.01% 2621
2026
Q1
$133K Buy
+58,742
New +$124K ﹤0.01% 2756

Other funds holding IPSC

American Century Companies's IPSC Position: Q2 2026 in Review

American Century Companies increased its Century Therapeutics (IPSC) stake by 196% in Q2 2026, buying an estimated $263K and bringing the position to 174,062 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #2621.

American Century Companies first reported a position in IPSC in Q1 2026 and has held it in 2 quarters since. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • American Century Companies held 174,062 shares of Century Therapeutics worth $426K as of Q2 2026.
  • American Century Companies bought 115,320 Century Therapeutics shares in Q2 2026, an estimated $263K.
  • Century Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2621 holding.
  • American Century Companies first reported a position in Century Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.